The aims of this study in hemodialysis (HD) patients were: 1. To evaluate the relationship of calf bioimpedance with total body composition and fluid status as measured by gold standard methods. 2. To investigate the ability of calf normalized resistivity (CNR) to predict the normal fluid status (dry weight: DW) in a prospective study. In the body composition study (n = 41), fluid status (ECVBr/FFMMRI), muscle mass (MMMRI), and total adipose tissue (TATMRI) were measured by dilution (D2O and Br) and MRI methods three hours prior to HD treatment. Calf extracellular and intracellular resistance, resistivity, and CNR were measured with a multi-frequency bioimpedance device (Hydra 4200). In the fluid status study (n = 32 with 429 measurements), a nonlinear model based on the differences in CNR between patients and healthy subjects was established to predict DWcBIS previously determined by a separate continuous calf bioimpedance spectroscopy (cBIS) method. CNR significantly correlated with a gold standard hydration marker (ECVBr/FFMMRI). Calf body composition models were highly correlated with MMMRI (R2 = 0.85) and TATMRI (R2 = 0.85). DWcBIS prediction was validated with a CNR model in the degree of differences of 0.94 ± 0.18, 0.39 ± 0.7 and -0.02 ± 0.8 kg from DWcBIS when post HD fluid overload was 1.8 ± 1.2, 1.15 ± 0.8 and 0.54 ± 0.5 kg, respectively. These differences are not considered to be clinically significant. Conclusion: This practical method of calf bioimpedance is useful to predict body composition and normal fluid status in dialysis patients.

Keywords:
Calf bioimpedance, Body composition, Normal fluid status, Dialysis
1.
Kooman JP, van der Sande FM, Leunissen KM: Wet or dry in dialysis - can new technologies help? Semin Dial 2009;22:9-12.
2.
Dou Y, Zhu F, Kotanko P: Assessment of extracellular fluid volume and fluid status in hemodialysis patients: current status and technical advances. Semin Dial 2012;25:377-387.
3.
Kotanko P, Levin NW, Zhu F: Current state of bioimpedance technologies in dialysis. Nephrol Dial Transplant 2008;23:808-812.
4.
Piccoli A: Identification of operational clues to dry weight prescription in hemodialysis using bioimpedance vector analysis. The Italian Hemodialysis-Bioelectrical Impedance Analysis (HD-BIA) Study Group. Kidney Int 1998;53:1036-1043.
5.
Chamney PW, Wabel P, Moissl UM, Muller MJ, Bosy-Westphal A, Korth O, Fuller NJ: A whole-body model to distinguish excess fluid from the hydration of major body tissues. Am J Clin Nutr 2007;85:80-89.
6.
Zhu F, Kuhlmann MK, Kotanko P, Seibert E, Leonard EF, Levin NW: A method for the estimation of hydration state during hemodialysis using a calf bioimpedance technique. Physiol Meas 2008;29:S503-S516.
7.
Kuhlmann MK, Zhu F, Seibert E, Levin NW: Bioimpedance, dry weight and blood pressure control: new methods and consequences. Curr Opin Nephrol Hypertens 2005;14:543-549.
8.
Kyle UG, Bosaeus I, De Lorenzo AD, Deurenberg P, Elia M, Gomez JM, Heitmann BL, Kent-Smith L, Melchior JC, Pirlich M, Scharfetter H, Schols AM, Pichard C: Bioelectrical impedance analysis - part I: review of principles and methods. Clin Nutr 2004;23:1226-1243.
9.
Davies SJ, Davenport A: The role of bioimpedance and biomarkers in helping to aid clinical decision-making of volume assessments in dialysis patients. Kidney Int 2014;86:489-496.
10.
Onofriescu M, Hogas S, Voroneanu L, Apetrii M, Nistor I, Kanbay M, Covic AC: Bioimpedance-guided fluid management in maintenance hemodialysis: a pilot randomized controlled trial. Am J Kidney Dis 2014;64:111-118.
11.
Wabel P, Chamney P, Moissl U, Jirka T: Importance of whole-body bioimpedance spectroscopy for the management of fluid balance. Blood Purif 2009;27:75-80.
12.
Zhu F, Schneditz D, Wang E, Levin NW: Dynamics of segmental extracellular volumes during changes in body position by bioimpedance analysis. J Appl Physiol 1998;85:497-504.
13.
Carter M, Morris AT, Zhu F, Zaluska W, Levin NW: Effect of body mass index (BMI) on estimation of extracellular volume (ECV) in hemodialysis (HD) patients using segmental and whole body bioimpedance analysis. Physiol Meas 2005;26:S93-S99.
14.
Abbas SR, Liu L, Sipahioglu MH, Rosales L, Carter M, Kotanko P, Levin NW, Zhu F: Comparison of bioimpedance techniques to detect changes in fluid status in hemodialysis patients. Blood Purif 2014;37:48-56.
15.
Liu L, Zhu F, G Raimann J, Thijssen S, Sipahioglu MH, Wystrychowski G, Kitzler T, Tetta C, Wabel P, Kotanko P, Levin NW: Determination of fluid status in haemodialysis patients with whole body and calf bioimpedance techniques. Nephrology (Carlton) 2012;17:131-140.
16.
Tattersall J: Bioimpedance analysis in dialysis: state of the art and what we can expect. Blood Purif 2009;27:70-74.
17.
Sarkar SR, Kuhlmann MK, Khilnani R, Zhu F, Heymsfield SB, Kaysen GA, Levin NW: Assessment of body composition in long-term hemodialysis patients: rationale and methodology. J Ren Nutr 2005;15:152-158.
18.
Zhu F, Leonard EF, Levin NW: Body composition modeling in the calf using an equivalent circuit model of multi-frequency bioimpedance analysis. Physiol Meas 2005;26:S133-S143.
19.
Zhu F, Kotanko P, Handelman GJ, Raimann JG, Liu L, Carter M, Kuhlmann MK, Seibert E, Leonard EF, Levin NW: Estimation of normal hydration in dialysis patients using whole body and calf bioimpedance analysis. Physiol Meas 2011;32:887-902.
20.
Patterson R, Ranganathan C, Engel R, Berkseth R: Measurement of body fluid volume change using multisite impedance measurements. Med Biol Eng Comput 1988;26:33-37.
21.
Thomas BJ, Ward LC, Cornish BH: Bioimpedance spectrometry in the determination of body water compartments: accuracy and clinical significance. Appl Radiat Isot 1998;49:447-455.
22.
Cox-Reijven PL, Kooman JP, Soeters PB, van der Sande FM, Leunissen KM: Role of bioimpedance spectroscopy in assessment of body water compartments in hemodialysis patients. Am J Kidney Dis 2001;38:832-838.
23.
Kyle UG, Bosaeus I, De Lorenzo AD, Deurenberg P, Elia M, Manuel Gomez J, Lilienthal Heitmann B, Kent-Smith L, Melchior JC, Pirlich M, Scharfetter H, M W J Schols A, Pichard C: Bioelectrical impedance analysis - part II: utilization in clinical practice. Clin Nutr 2004;23:1430-1453.
24.
Hoenich NA, Levin NW: Can technology solve the clinical problem of ‘dry weight'? Nephrol Dial Transplant 2003;18:647-650.
© 2015 S. Karger AG, Basel
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.